Understanding Adrenal Cortical Adenoma: This guide covers Adrenal Adenoma, also known as a Benign Adrenal Tumor, focusing on diagnosis, clinical documentation, and medical coding for healthcare professionals. Learn about Adrenal Cortical Adenoma symptoms, treatment, and relevant medical coding terminology for accurate clinical documentation and improved patient care.
Also known as
Hyperaldosteronism
Overproduction of aldosterone by the adrenal glands.
Benign neoplasm of adrenal gland
Non-cancerous tumor of the adrenal gland.
Endocrine, nutritional and metabolic diseases
Disorders affecting hormone production, metabolism, and nutrition.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the adrenal adenoma functioning or non-functioning?
When to use each related code
| Description |
|---|
| Benign adrenal gland tumor. |
| Cancerous adrenal gland tumor. |
| Overactive adrenal gland. |
Missing or unspecified laterality (right, left, bilateral) can lead to coding errors and claim denials. Proper documentation is crucial for accurate coding (ICD-10-CM D35.0-). CDI review is essential.
Distinguishing between adrenal and adrenal cortical adenoma is crucial. Incorrect coding can impact medical necessity reviews and reimbursement. ICD-10-CM specificity is needed for compliance.
Accurate differentiation between benign and malignant tumors is paramount for treatment and coding. Healthcare compliance mandates proper documentation and coding (ICD-10-CM D35.0-) to avoid errors.
Q: What are the key differentiating factors in adrenal cortical adenoma imaging characteristics between benign and potentially malignant lesions?
A: Differentiating benign adrenal cortical adenomas from malignant lesions on imaging can be challenging. Benign adenomas typically present as small (<4cm), homogenous, well-circumscribed masses with low attenuation on non-contrast CT due to high intracellular lipid content. Washout studies demonstrate rapid contrast washout, typically greater than 60% at 10 minutes. Conversely, concerning features suggestive of malignancy include larger size (>4cm), irregular borders, heterogeneous enhancement, areas of necrosis, calcification, and slower washout. Delayed contrast washout of less than 40% at 10 minutes raises suspicion for adrenocortical carcinoma. Chemical shift MRI can also be helpful, with benign adenomas demonstrating a significant signal loss on out-of-phase imaging. However, biopsy or surgical resection may ultimately be required for definitive diagnosis. Explore how S10.AI can assist in the analysis of adrenal imaging for enhanced diagnostic accuracy.
Q: How should I manage an incidentally discovered adrenal cortical adenoma in an asymptomatic patient, and what follow-up protocol should be implemented?
A: The management of an incidentally discovered adrenal cortical adenoma (incidentaloma) in an asymptomatic patient depends on its size and imaging characteristics. For small (<4cm), homogenous adenomas without concerning features on imaging (e.g., rapid contrast washout, signal loss on out-of-phase MRI), hormonal evaluation is recommended to exclude subclinical hormone overproduction (e.g., cortisol, aldosterone, catecholamines). If hormone levels are normal, repeat imaging (CT or MRI) in 6-12 months and then periodically (e.g., every 2-3 years) is generally sufficient. Larger adenomas (>4cm) or those with suspicious imaging characteristics warrant further evaluation with dedicated adrenal protocol CT or MRI and consideration of adrenalectomy, even in the absence of overt hormone excess. Consider implementing a standardized protocol for incidental adrenal mass evaluation in your practice. Learn more about best practices for managing adrenal incidentalomas.
Patient presents with signs and symptoms suggestive of an adrenal cortical adenoma, including possible subclinical Cushing syndrome, primary aldosteronism (Conn syndrome), or incidentally discovered adrenal mass. Evaluation for adrenal adenoma includes a detailed medical history, physical examination, and biochemical testing. Hormonal evaluation was conducted to assess for cortisol, aldosterone, and renin levels. Imaging studies, such as an abdominal CT scan with adrenal protocol or adrenal MRI, were performed to characterize the adrenal mass and determine its size and characteristics. Differential diagnosis considered other adrenal lesions, including adrenal carcinoma, pheochromocytoma, and non-functioning adrenal adenoma. Based on the clinical presentation, laboratory findings, and imaging results, the diagnosis of adrenal cortical adenoma is suspected. Management options include active surveillance with repeat imaging and hormonal testing, surgical resection (adrenalectomy) for hormonally active adenomas or large masses, and medical management for specific hormonal excess. Patient education was provided regarding the nature of adrenal adenomas, potential complications, and follow-up recommendations. The patient was advised to follow up for ongoing monitoring and management of their adrenal adenoma. ICD-10 code D35.0, benign neoplasm of adrenal gland, and appropriate CPT codes for imaging and laboratory studies were documented.